References
- WilconLATo preserve or not to preserve, is that the question?Br J Ophthalmol1996805835848795365
- De Saint JeanMDebbaschCBrignoleFToxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cellsCurr Eye Res200020859410617908
- BursteinNLCorneal cytotoxicity of topically applied drugs, vehicles and preservativesSurv Ophthalmol19802515306998034
- BursteinNLThe effects of topical drugs and preservatives on the tears and corneal epithelium in dry eyeTrans Ophthalmol Soc UK19851044024093898475
- De JongCSolwijkTKuppensETopical timolol with and without benzalkonium chloride; epithelial permeability and autofluorescence of the cornea in glaucomaGraefes Arch Clin Exp Ophthalmol19942322212248034210
- MietzHNiesenUKrieglsteinGKThe effect of preservatives and antiglaucomatous medication on the histopathology of the conjunctivaGraefes Arch Clin Exp Ophthalmol19942325615657959096
- PisellaPJFillacierKElenaPComparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbitsOphthalmic Res2000323810657748
- NoeckerREffects of common ophthalmic preservatives on ocular healthAdv Ther20011820521511783457
- BaudouinCde LunardoCShort term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteersBr J Ophthalmol19988239429536878
- NornMSOpauszkiAEffects of ophthalmic vehicles on the stability of the precorneal tear filmActa Ophthalmol197755233465897
- YalvaçISGedikoğluGKaragözYEffects of antiglaucoma drugs on ocular surfaceActa Ophthalmol Scand1995732462487493237
- KuppensEVde JongCAStolwijkTREffect of timolol with and without preservative on the basal tear turnover in glaucomaBr J Ophthalmol1995793393427742279
- WilsonWSDuncanAJJayJLEffect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and manBr J Ophthalmol1975596676691203224
- HerrerasJMPastorJCCalongeMOcular surface alteration after long-term treatment with an antiglaucomatous drugOphthalmology199299108210881495787
- RolandoMBrezzoVGiordanoGvan BijsterveldOPLempMASpinelliDSymposium on the lacrimal system Singapore, 31990AmsterdamKugler and Ghedini19918791
- HollyFJTear film formation and rupture: an updateHollyFJThe precorneal tear film in health diseases and contact lens wearDry Eye Institute IncLubbock1986634645
- BursteinNLPreservative cytotoxic threshold for benzalkonium chloride and Chlorhexidine digluconate in cat and rabbit corneasInvest Ophthalmol Vis Sci1980193083137358482
- MarquardtRSchubertTBeeinflussung der Tränenfilmaufreisszeit (BUT) durch Betablocker-Augentropfen ohne KonservierungstoffeKlin Monatsbl Augenheilkd199119975781960936
- KahookMNoeckerRComparison of corneal and conjunctival changes after dosing of travoprost preserved with SofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tearsCornea20082733934318362664
- NoeckerRJHerrygersLAAnwaruddinRCorneal and conjunctival changes caused by commonly used glaucoma medicationsCornea20042349049615220734
- BroadwayDCGriersonIO’BrienCHitchingsRAAdverse effects of topical antiglaucoma medication. II. The outcome of filtration surgeryArch Ophthalmol199411211144614547980134
- YeeRWNorcomEGZhaoXCComparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture systemAdv Ther20062351151917050493
- SchiffmanRMChristiansonMDReliability and validity of the Ocular Surface Disease IndexArch Ophthalmol200011861562110815152
- WhitsonJTCavanaghHDLakshmanNAssessment of corneal epithelial integrity after exposure to ocular hypotensive agents preserved with and without benzalkonium chlorideAdv Ther20062366367117142200
- LewisRAKatzGJWeissMJTravoprost 0.004% with and without benzalkonium chloride: a comparison of safety and efficacyJ Glaucoma2007169810317224758